Nrf2 Activation and Antioxidant Properties of Chromone-Containing MTDLs for Alzheimer’s Disease Treatment
Open Access
Abstract
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder affecting millions worldwide and imposing a significant social and economic burden. Despite extensive research, there is still no effective cure for this disease. AD is multifactorial and involves multiple etiopathogenic mechanisms, one of which is oxidative stress. Consequently, the Nrf2/ARE pathway, which regulates the expression of cellular defense genes, including those for antioxidant enzymes, is considered to be a prospective therapeutic target for AD. Meanwhile, multitarget-directed ligands (MTDLs) are a promising approach for developing effective AD medications. In this regard, we evaluated the antioxidant potential of eight chromone-containing MTDLs in vitro, including Nrf2 transcriptional activation potencies, Nrf2/ARE downstream genes activation, and antioxidant effects in vitro. All tested compounds effectively activated the Nrf2/ARE pathway. Notably, compounds 4b, 4c, 4f, and 4h demonstrated the highest Nrf2 activation potencies, while compounds 4b, 4c, 4d, and 4g significantly induced the expression of Nrf2-target antioxidant genes, specifically NQO1 and HO1. Additionally, compound 4d exhibited a significant antioxidant effect in vitro. These findings encourage further investigation of the studied compounds, with particular emphasis on compound 4d as the most promising candidate.Keywords
This publication has 39 references indexed in Scilit:
- Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: A value of statistical life approacheClinicalMedicine, 2022
- Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s diseaseAgeing Research Reviews, 2022
- Emerging roles of oxidative stress in brain aging and Alzheimer's diseaseNeurobiology of Aging, 2021
- Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implicationsFree Radical Biology and Medicine, 2021
- Discovery of natural flavonoids as activators of Nrf2-mediated defense system: Structure-activity relationship and inhibition of intracellular oxidative insultsBioorganic & Medicinal Chemistry, 2018
- Specificity of Stress‐Responsive Transcription Factors Nrf2, ATF4, and AP‐1Journal of Cellular Biochemistry, 2016
- Induction of NRF2‐mediated gene expression by dietary phytochemical flavones apigenin and luteolinBiopharmaceutics & Drug Disposition, 2015
- Metal dyshomeostasis and oxidative stress in Alzheimer’s diseaseNeurochemistry International, 2013
- Induction of Heme Oxygenase-1 (HO-1) and NAD[P]H: Quinone Oxidoreductase 1 (NQO1) by a Phenolic Antioxidant, Butylated Hydroxyanisole (BHA) and Its Metabolite, tert-Butylhydroquinone (tBHQ) in Primary-Cultured Human and Rat HepatocytesPharmaceutical Research, 2006
- A “mitochondrial cascade hypothesis” for sporadic Alzheimer's diseaseMedical Hypotheses, 2004